Cboe May Have Found the Next Retail Derivatives Rail

Written by Julia Rostova

Cboe Global Markets may have stumbled into one of the more interesting exchange narratives of the summer. The immediate catalyst is Charles Schwab’s reported partnership with Cboe to introduce S&P 500 event contracts, a structure Reuters described as an all-or-nothing options format that lets clients express a yes-or-no view on market outcomes through a mainstream brokerage channel. On its face, that sounds like a niche product tweak. In reality, it could become a revealing test of whether regulated exchanges can turn prediction-market mechanics into a broader retail-derivatives business without inheriting the political and legal baggage attached to sports or election betting.

The reason this matters most for Cboe is simple. Distribution has always been the decisive variable in exchange products. New contracts do not become meaningful because they are clever. They become meaningful because they are easy to access, legible to customers, and embedded inside an existing brokerage habit loop. An accessible summary of the Schwab-Cboe initiative notes that the firms are developing regulated S&P 500 event contracts for more than 35 million Schwab clients. If even a modest share of that base experiments with short-duration directional products, Cboe gains something more valuable than a one-off volume pop. It gains a new retail on-ramp into exchange-traded risk.

There is a broader industry point here. Exchanges have spent years searching for growth beyond the mature playbook of benchmark options, index futures, clearing, and data. The next leg of growth will likely come from product formats that compress market opinions into simpler, faster, more intuitive structures. Event contracts fit that need. They are easier for many retail investors to understand than multi-leg options strategies, but they still sit inside a regulated market framework. That makes them strategically attractive to brokers that want engagement without pushing clients fully into off-exchange speculation.

For Cboe specifically, the attraction is that this product plays to its strengths. The company already understands listed options market design, retail flow, and how to seed product adoption through brokerage channels. What it has lacked, at times, is a cleaner narrative for why it deserves a higher multiple than a steady but mature market-operator profile. This Schwab partnership offers one. It says Cboe is not merely defending a legacy franchise. It is experimenting with how the next generation of retail trading behavior may be packaged.

That does not make the stock risk-free. Exchange innovation often looks exciting before the revenue contribution is visible. Event contracts can draw regulatory scrutiny if they are seen as marketing short-term wagering rather than investment tools. And Cboe still faces competition from larger incumbents with deeper clearing, futures, and data ecosystems. But this is where the comparison set becomes useful.

Charles Schwab, or SCHW, is the most direct distribution beneficiary. With the stock recently around $91.69 and consensus targets near $116, Schwab has meaningful upside if management can turn event contracts into just one more engagement lever inside its larger asset-gathering machine. I rate SCHW a BUY with a $112 price target. The company does not need this product to transform its economics overnight. It only needs it to reinforce client activity, trading relevance, and product breadth.

Cboe, or CBOE, looks even more interesting in this specific setup. Accessible valuation snippets place the average target near $326.93, implying material upside from current levels. I am slightly more conservative and assign CBOE a BUY with a $320 price target. The stock deserves that stance because it has a fresh catalyst, direct exposure to product adoption, and an exchange model that can scale incremental volume efficiently if event contracts find traction.

By contrast, CME Group remains a first-class franchise but a less obvious winner from this particular development. Recent snippets suggest the stock has been trading around $246 to $253, while average targets cluster near $309 to $312. I rate CME a HOLD with a $300 price target. It remains a quality compounder, but its current setup is more about franchise durability than a newly forming retail-volume narrative.

The same logic applies to Intercontinental Exchange. ICE is a strong operator with durable assets, but the stock has recently traded near $134 and consensus targets mostly sit in the $193 to $204 range. I rate ICE a HOLD with a $185 price target. The company has quality, but the immediate catalyst here belongs elsewhere.

The cleanest way to frame the trade is this: Schwab brings the customers, Cboe brings the market structure, and the product itself could tell us whether regulated event contracts become a durable retail category or remain a curiosity. If the category works, Cboe stands to gain the most from multiple expansion because the market will start viewing it less as a mature exchange utility and more as a platform still capable of inventing new trading habits. That is the kind of narrative shift that can matter disproportionately for a stock.

For now, the verdict is straightforward. CBOE: BUY, $320. SCHW: BUY, $112. CME: HOLD, $300. ICE: HOLD, $185. The catalyst is fresh, the distribution channel is credible, and the market may be underestimating how important a simple product format can be when it arrives through the right brokerage pipe.